📣 VC round data is live. Check it out!
- Public Comps
- Pilulka Lekarny
Pilulka Lekarny Valuation Multiples
Discover revenue and EBITDA valuation multiples for Pilulka Lekarny and similar public comparables like Digital Brands Group, MOGU, Westwing Brasil, Laxus Technologies and more.
Pilulka Lekarny Overview
About Pilulka Lekarny
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.
Founded
2014
HQ

Employees
N/A
Website
Financials (FY)
EV
$19M
Valuation Multiples
Start free trialPilulka Lekarny Financials
Pilulka Lekarny reported last fiscal year revenue of $63M and negative EBITDA of ($2M).
In the same fiscal year, Pilulka Lekarny generated $6M in gross profit, ($2M) in EBITDA losses, and had net loss of ($6M).
Pilulka Lekarny P&L
In the most recent fiscal year, Pilulka Lekarny reported revenue of $63M and EBITDA of ($2M).
Pilulka Lekarny is unprofitable as of last fiscal year, with gross margin of 9%, EBITDA margin of (4%), and net margin of (10%).
Financial data powered by Morningstar, Inc.
Pilulka Lekarny Stock Performance
Pilulka Lekarny has current market cap of $17M, and enterprise value of $19M.
Market Cap Evolution
Pilulka Lekarny's stock price is $6.28.
Pilulka Lekarny share price decreased by 1.8% in the last 30 days, and by 33.2% in the last year.
Pilulka Lekarny has an EPS (earnings per share) of $-2.23.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $19M | $17M | -3.1% | -1.8% | 23.2% | -33.2% | $-2.23 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPilulka Lekarny Valuation Multiples
Pilulka Lekarny trades at 0.3x EV/Revenue multiple, and (7.9x) EV/EBITDA.
Pilulka Lekarny Financial Valuation Multiples
As of June 3, 2026, Pilulka Lekarny has market cap of $17M and EV of $19M.
Pilulka Lekarny has a P/E ratio of (2.8x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Pilulka Lekarny Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Pilulka Lekarny Margins & Growth Rates
In the most recent fiscal year, Pilulka Lekarny reported gross margin of 9%, EBITDA margin of (4%), and net margin of (10%).
Pilulka Lekarny Margins
Pilulka Lekarny Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Pilulka Lekarny Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Pilulka Lekarny Competitors
Pilulka Lekarny competitors include Digital Brands Group, MOGU, Westwing Brasil, Laxus Technologies, Farmacosmo, Goodfood Market, MedTech Solutions, MERLIN GROUP, Rise and Moliera2.
Most Pilulka Lekarny public comparables operate across Consumer E-commerce, Pharmacies, Vertical E-commerce and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | - | - | - | |||
| (2.1x) | - | 7.0x | - | |||
| (0.1x) | - | (1.9x) | - | |||
| 0.9x | 1.0x | 2.6x | - | |||
| 0.4x | - | 63.4x | - | |||
| 0.5x | 0.6x | 10.5x | 43.1x | |||
| 148.0x | - | (17.9x) | - | |||
| - | - | - | - | |||
This data is available for Pro users. Sign up to see all Pilulka Lekarny competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Pilulka Lekarny
| When was Pilulka Lekarny founded? | Pilulka Lekarny was founded in 2014. |
| Where is Pilulka Lekarny headquartered? | Pilulka Lekarny is headquartered in Czech Republic. |
| Is Pilulka Lekarny publicly listed? | Yes, Pilulka Lekarny is a public company listed on Prague Stock Exchange. |
| What is the stock symbol of Pilulka Lekarny? | Pilulka Lekarny trades under PINK ticker. |
| When did Pilulka Lekarny go public? | Pilulka Lekarny went public in 2020. |
| Who are competitors of Pilulka Lekarny? | Pilulka Lekarny main competitors include Digital Brands Group, MOGU, Westwing Brasil, Laxus Technologies, Farmacosmo, Goodfood Market, MedTech Solutions, MERLIN GROUP, Rise, Moliera2. |
| What is the current market cap of Pilulka Lekarny? | Pilulka Lekarny's current market cap is $17M. |
| What is the current revenue of Pilulka Lekarny? | Pilulka Lekarny's last fiscal year revenue is $63M. |
| What is the current EV/Revenue multiple of Pilulka Lekarny? | Current revenue multiple of Pilulka Lekarny is 0.3x. |
| Is Pilulka Lekarny profitable? | No, Pilulka Lekarny is not profitable. |
| How many companies Pilulka Lekarny has acquired to date? | Pilulka Lekarny hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Pilulka Lekarny has invested to date? | Pilulka Lekarny hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Pilulka Lekarny
Lists including Pilulka Lekarny
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.